Vizsgálati helyszín

Accellacare

Wilmington, North Carolina, Egyesült ÁllamokMég nincs intézményhez kötve

7futó vizsgálat
14lezárt vizsgálat
0a helyszín által az elmúlt 60 napban megerősített vizsgálat
–nyelv nincs megadva

A helyszín még egy vizsgálatot sem erősített meg.

Futó vizsgálatok

Toboroz
A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
NCT07919678· 3. fázis· Forrás
Toboroz
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
NCT07607587· 1. fázis· Forrás
Toboroz
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
NCT07521475· Forrás
Fut, nem toboroz
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
NCT07220759· 3. fázis· Forrás
Fut, nem toboroz
A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
NCT07011667· 3. fázis· Forrás
Fut, nem toboroz
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401· 2. fázis· Forrás
Fut, nem toboroz
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
NCT05567796· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Elhízás2 toboroz
2-es típusú cukorbetegség1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

Lezárult
Simplified Onboarding in Adults With Type 2 Diabetes
NCT07070830· Forrás
Lezárult
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
NCT06388187· 3. fázis· Forrás
Lezárult
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
NCT06326060· 2. fázis· Forrás
Lezárult
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
NCT06221969· 3. fázis· Forrás
Lezárult
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
NCT06131437· 3. fázis· Forrás
Lezárult
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
NCT06065540· 3. fázis· Forrás
Lezárult
OP5-005 Using Omnipod 5 in Adults With Type 2
NCT05815342· Forrás
Lezárult
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
NCT05564117· 3. fázis· Forrás
Lezárult
A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
NCT05486065· 2. fázis· Forrás
Lezárult
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
NCT05259033· 3. fázis· Forrás
Lezárult
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
NCT05013229· 3. fázis· Forrás
Leállították
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
NCT04804033· 2/3. fázis· Forrás
Lezárult
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
NCT03819153· 3. fázis· Forrás
Lezárult
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
NCT03914326· 3. fázis· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 11.

Hibát jelzek